%0 Journal Article %A Teresa Furlan %A Eduardo Massad %T Cost-effectiveness analysis of diagnostics tests of respiratory tract infection in cancer patients %D 2016 %R 10.1183/13993003.congress-2016.PA2594 %J European Respiratory Journal %P PA2594 %V 48 %N suppl 60 %X Patients with alterations in the immune system are more susceptible to developing complications caused by virus, as well as acute respiratory infection (ARI).This cross-sectional study assessed diagnostic tests for ARI from samples of nasopharyngeal materials. Those samples were acquired from patients diagnosed with cancer and submitted in treatment at two Cancer Center. The study considered 151 patients predominantly female (81 women and 70 men) aged 18-86 years. Were used rapid test by Influenza A, B, (H1N1) and RSV and RT-PCR Multiplex for 21 virus and bacteria. In 81 (53.6%) of 151 patients, there were at least one positive result to rapid test, to Molecular Biology or both. As a result the clinician can opt for hospital discharge and the patient receives treatment at home.Were analyzed the impact of the introduction of diagnostic tests on the outcome of treatment and, the economic viability in the public and private health system in Brazil.The Economic Evaluation compared the use of resources for introduction of tests for the diagnosis of respiratory viruses at the expense of absence of the use of tests. The direct and indirect costs were analyzed, and the benefits to the patient and her escort. In addition, we evaluated the cost of this intervention to the public and private health system for the days of avoided hospitalization.In the private system the cost benefit ratio indicated that each dollar invested in tests 4 were saved. Despite the unfavorable cost of testing for the public system, early intervention can cooperate on patient outcome, on avoiding the indiscriminate use of antibiotics and on contamination of other patients and health professionals. %U